Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.
Brenchley
P E
PE
D043925:Angiogenesis Inducing Agents / Q000502:physiology; D001168:Arthritis / Q000150:complications* / Q000473:pathology / Q000628:therapy; D016207:Cytokines / Q000502:physiology; D016228:Endothelial Growth Factors / Q000235:genetics / Q000502:physiology; D005109:Extracellular Matrix / Q000378:metabolism; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D008222:Lymphokines / Q000235:genetics / Q000502:physiology; D009389:Neovascularization, Pathologic / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D015854:Up-Regulation; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D043925:Angiogenesis Inducing Agents; D016207:Cytokines; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors